Luigi Portella

1.7k citations
30 papers · 1.0k indexed · h-index 18
Topics
Chemokine receptors and signaling (17 papers)Immunotherapy and Immune Responses (14 papers)Cancer Immunotherapy and Biomarkers (7 papers)

In The Last Decade

Luigi Portella

30 papers receiving 1.0k citations

Peers

Luigi Portella
Comparison fields: 5 of 72
  • Oncology 554
  • Immunology 378
  • Pulmonary and Respiratory Medicine 364
  • Molecular Biology 353
  • Cancer Research 201
Replace Toni M. Brand with:
Toni M. Brand United States
Alberto Fusi Germany
Linda N. Liu United States
Vinay Sagar United States
Nader Al Nakouzi Canada
Caining Jin United States
Ina Kurth Germany
Bertha Brodin Sweden
Frank J. Lowery United States
Jeonghee Cho South Korea
Luigi Portella relative to Toni M. Brand United States Toni M. Brand's profile →
Citations per field
00.5×1.5×
Toni M. Brand · 1×
Citations per year

Countries citing papers authored by Luigi Portella

Since Specialization
Citations

This map shows the geographic impact of Luigi Portella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luigi Portella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luigi Portella more than expected).

Fields of papers citing papers by Luigi Portella

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luigi Portella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luigi Portella. The network helps show where Luigi Portella may publish in the future.

Co-authorship network of co-authors of Luigi Portella

This figure shows the co-authorship network connecting the top 25 collaborators of Luigi Portella. A scholar is included among the top collaborators of Luigi Portella based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luigi Portella. Luigi Portella is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 10
2 14
3 8
4 42
5 17
6 81
7 53
8 86
9 18
10 1
11 27
12 4
13 191
14 43
15 47
16 76
17 57
18 14
19 67
20 12

About Luigi Portella

Luigi Portella is a scholar working on Immunology, Oncology and Hematology, having authored 30 papers that have together received 1.0k indexed citations. Recurring topics across this work include Chemokine receptors and signaling (17 papers), Immunotherapy and Immune Responses (14 papers) and Cancer Immunotherapy and Biomarkers (7 papers). The work is most often cited by research in Oncology (554 citations), Immunology (378 citations) and Cancer Research (201 citations). Luigi Portella has collaborated with scholars based in Italy, United States and Switzerland. Frequent co-authors include Stefania Scala, Paraskevi Giannakakou, David M. Nanus, Crescenzo D’Alterio, Maria Napolitano, Caterina Ieranò, Stephen R. Plymate, Shihua Sun, Alexandre Matov and Maria Thadani‐Mulero. Their work appears in journals such as PLoS ONE, Cancer Research and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026